Orion

Orion ORINY Stock

$56.16   -1.074512%
Add to favorites
Market Cap
$15.75B
LOW - HIGH [24H]
$53.99 - $53.99
VOLUME [24H]
$12.00
P/E Ratio
20.64
Earnings per share
$2.72
ISIN
US68628Y1047
Price   Prediction

Orion Price Chart

Sorry, that's all we've gotfor now...

Orion (ORINY) stock price today is 56.16 USD on OTC Markets OTCPK (-1.07% on the day). Updated .

Orion ORINY Financial and Trading Overview

Orion stock price 56.16 USD
Previous Close 56.77 USD
Open 53.99 USD
Bid 37.26 USD x 35500
Ask 76.99 USD x 20000
Day's Range 53.99 - 53.99 USD
52 Week Range 33.63 - 58.15 USD
Volume 12 USD
Avg. Volume 798 USD
Market Cap 15.14B USD
Beta (5Y Monthly) 0.231
PE Ratio (TTM) 19.849266
EPS (TTM) 2.72 USD
Forward Dividend & Yield 1.02 (1.79%)
Ex-Dividend Date October 20, 2026
1y Target Est N/A

ORINY Valuation Measures

Enterprise Value 15.92B USD
Trailing P/E 19.849266
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 6.9566503
Price/Book (mrq) 9.647417
Enterprise Value/Revenue 7.313
Enterprise Value/EBITDA 17.999

Trading Information

Orion Stock Price History

Beta (5Y Monthly) 0.231
52-Week Change 68.83%
S&P500 52-Week Change 8.67%
52 Week High 58.15 USD
52 Week Low 33.63 USD
50-Day Moving Average 51.35 USD
200-Day Moving Average 42.9 USD

ORINY Share Statistics

Avg. Volume (3 month) 798 USD
Avg. Daily Volume (10-Days) 355 USD
Shares Outstanding 280.48M
Float 245.98M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.8
Trailing Annual Dividend Yield 3.17%
5 Year Average Dividend Yield 294.00%
Payout Ratio 0.3732
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 30.25%
Operating Margin (ttm) 38.11%
Gross Margin 67.44%
EBITDA Margin 40.62%

Management Effectiveness

Return on Assets (ttm) 27.42%
Return on Equity (ttm) 54.49%

Income Statement

Revenue (ttm) 2.18B USD
Revenue Per Share (ttm) 7.73 USD
Quarterly Revenue Growth (yoy) 28.10%
Gross Profit (ttm) 1.47B USD
EBITDA 884.4M USD
Net Income Avi to Common (ttm) 658.7M USD
Diluted EPS (ttm) 2.72
Quarterly Earnings Growth (yoy) 74.59%

Balance Sheet

Total Cash (mrq) 144.3M USD
Total Cash Per Share (mrq) 0.51 USD
Total Debt (mrq) 125.5M USD
Total Debt/Equity (mrq) 8.98 USD
Current Ratio (mrq) 2.722
Book Value Per Share (mrq) 5.596317

Cash Flow Statement

Operating Cash Flow (ttm) 489.4M USD
Levered Free Cash Flow (ttm) 271.4M USD

Profile of Orion

Country United States
State N/A
City Espo
Address Orionintie 1A
ZIP 02200
Phone 358 10 4261
Website https://www.orionpharma.com
Industry Drug Manufacturers - General
Sector(s) Healthcare
Full Time Employees 4215

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer; Quetiapine products for antipsychotic; Trexan for rheumatoid arthritis and cancer; Easyhaler product portfolio for asthma and COPD; and Dexdor, Precedex, and Dexmedetomidine products for human use. The company also provides Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, it offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells drugs and products manufactured by other companies. Additionally, the company provides self-care products, including non-prescription medicines, cosmetics, dietary supplements, vitamins, and skincare products. It also offers its products online. The company has a licensing agreement with Tenax Therapeutics, Inc. to develop oral levosimendan (TNX-103) for pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF); and Bayer for the development and commercialisation of darolutamide Nubeqa. Orion Oyj was founded in 1917 and is headquartered in Espo, Finland.

Q&A For Orion Stock

What is a current ORINY stock price?

Orion ORINY stock price today per share is 56.16 USD.

How to purchase Orion stock?

You can buy ORINY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Orion?

The stock symbol or ticker of Orion is ORINY.

Which industry does the Orion company belong to?

The Orion industry is Drug Manufacturers - General.

How many shares does Orion have in circulation?

The max supply of Orion shares is 280.48M.

What is Orion Price to Earnings Ratio (PE Ratio)?

Orion PE Ratio is 20.64705800 now.

What was Orion earnings per share over the trailing 12 months (TTM)?

Orion EPS is 2.72 USD over the trailing 12 months.

Which sector does the Orion company belong to?

The Orion sector is Healthcare.

$2.09T
Total marketcap
$111.4B
Total volume
BTC 57.91%   •   ETH 9.84%
Dominance
Select currency